When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 14 Hits
  • Search Condition : Filter (MeSH = Aniline Compounds / pharmacology)
Species Resource Title
Human and Animal Cells K562 Aldo-keto reductase inhibitors increase the anticancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia.
Human and Animal Cells Ba/F3(RCB4476) Lamellarin 14, a derivative of marine alkaloids, inhibits the T790M/C797S mutant epidermal growth factor receptor.
Human and Animal Cells A549(RCB0098) Lurasidone Sensitizes Cancer Cells to Osimertinib by Inducing Autophagy and Reduction of Survivin.
Human and Animal Cells B16/BL6(RCB2638) Accelerated growth of B16BL6 tumor in mice through efficient uptake of their own exosomes by B16BL6 cells.
Human and Animal Cells Ba/F3 Licochalcone A inhibits EGFR signalling and translationally suppresses survivin expression in human cancer cells.
Human and Animal Cells PC-9(RCB4455) Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer.
Human and Animal Cells CACO-2(RCB0988) Low‑dose trametinib and Bcl‑xL antagonist have a specific antitumor effect in KRAS‑mutated colorectal cancer cells.
Human and Animal Cells MDCK(RCB0995) Oligomer formation of Clostridium perfringens epsilon-toxin is induced by activation of neutral sphingomyelinase.
DNA material CSIV-TRE-RfA-UbC-KT (RDB12878) TXNIP induces growth arrest and enhances ABT263-induced apoptosis in mixed-lineage leukemia-rearranged acute myeloid leukemia cells.
Human and Animal Cells Ba/F3(RCB0805) , PC-9(RCB4455) TAS6417/CLN-081 Is a Pan-Mutation-Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant EGFR Mutations.
Human and Animal Cells HuCCT1(RCB1960) , TFK-1(RCB2537) Src as a Therapeutic Target in Biliary Tract Cancer.
Human and Animal Cells Hep G2 , HuH-7 1-[2-(2-Methoxyphenylamino)ethylamino]-3-(naphthalene-1-yloxy)propan-2-ol as a potential anticancer drug.
Human and Animal Cells Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
Human and Animal Cells MC3T3-E1(RCB1126) , ST2(RCB0224) , 293(RCB1637) MEK5 suppresses osteoblastic differentiation.